Stay updated on Safety Efficacy HMI-203 in MPS II Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.

Latest updates to the Safety Efficacy HMI-203 in MPS II Clinical Trial page
- Check2 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, signaling a minor, non-substantive update to the ClinicalTrials.gov page. No study data or details are changed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision/version indicator in the footer was updated from v3.5.2 to v3.5.3, reflecting a technical release rather than a change to the study record content.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedThe term Mucopolysaccharidosis, MPS-II was added to the page's keywords/MeSH terms. The term Mucopolysaccharidosis type 2 was removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 of the page; this appears to be a backend/version change rather than substantive alterations to study information.SummaryDifference0.1%

- Check66 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy HMI-203 in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy HMI-203 in MPS II Clinical Trial page.